Trial
NCT03643562
Niemann-Pick Type C Treatment With Adrabetadex for Symptoms of Brain and Nervous System
Phase IIITERMINATEDSAFETYConfidence: MEDIUM
Sponsor
Mandos LLC
Collaborators
—
Condition
Niemann-Pick Type C Disease
Intervention
Adrabetadex
Why stopped
Sponsor had determined that the benefit-risk profile of adrabetadex was not favorable and the clinical development program for adrabetadex was discontinued.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2024-01-17